Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1967 1
1971 1
1974 1
1978 1
1980 1
1982 4
1984 1
1985 2
1987 1
1989 2
1991 1
1993 1
1995 2
1996 2
1997 2
1998 3
1999 1
2000 5
2001 1
2002 2
2003 2
2004 4
2005 7
2006 7
2007 8
2008 3
2009 6
2010 5
2011 4
2012 3
2013 8
2014 3
2015 3
2016 2
2017 9
2018 7
2019 1
2020 4
2021 6
2022 3
2023 3
2024 2
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

121 results

Results by year

Filters applied: . Clear all
Page 1
Cluster Analysis Identifies Distinct Pathogenetic Patterns in C3 Glomerulopathies/Immune Complex-Mediated Membranoproliferative GN.
Iatropoulos P, Daina E, Curreri M, Piras R, Valoti E, Mele C, Bresin E, Gamba S, Alberti M, Breno M, Perna A, Bettoni S, Sabadini E, Murer L, Vivarelli M, Noris M, Remuzzi G; Registry of Membranoproliferative Glomerulonephritis/C3 Glomerulopathy; Nastasi. Iatropoulos P, et al. J Am Soc Nephrol. 2018 Jan;29(1):283-294. doi: 10.1681/ASN.2017030258. Epub 2017 Oct 13. J Am Soc Nephrol. 2018. PMID: 29030465 Free PMC article.
Safety and Preliminary Efficacy of Mesenchymal Stromal Cell (ORBCEL-M) Therapy in Diabetic Kidney Disease: A Randomized Clinical Trial (NEPHSTROM).
Perico N, Remuzzi G, Griffin MD, Cockwell P, Maxwell AP, Casiraghi F, Rubis N, Peracchi T, Villa A, Todeschini M, Carrara F, Magee BA, Ruggenenti PL, Rota S, Cappelletti L, McInerney V, Griffin TP, Islam MN, Introna M, Pedrini O, Golay J, Finnerty AA, Smythe J, Fibbe WE, Elliman SJ, O'Brien T; NEPHSTROM Trial Consortium. Perico N, et al. J Am Soc Nephrol. 2023 Oct 1;34(10):1733-1751. doi: 10.1681/ASN.0000000000000189. Epub 2023 Aug 10. J Am Soc Nephrol. 2023. PMID: 37560967 Free PMC article. Clinical Trial.
Rationale and design of the pragmatic clinical trial tREatment with Beta-blockers after myOcardial infarction withOut reduced ejection fracTion (REBOOT).
Rossello X, Raposeiras-Roubin S, Latini R, Dominguez-Rodriguez A, Barrabés JA, Sánchez PL, Anguita M, Fernández-Vázquez F, Pascual-Figal D, De la Torre Hernandez JM, Ferraro S, Vetrano A, Pérez-Rivera JA, Prada-Delgado O, Escalera N, Staszewsky L, Pizarro G, Agüero J, Pocock S, Ottani F, Fuster V, Ibáñez B; REBOOT-CNIC investigators. Rossello X, et al. Eur Heart J Cardiovasc Pharmacother. 2022 May 5;8(3):291-301. doi: 10.1093/ehjcvp/pvab060. Eur Heart J Cardiovasc Pharmacother. 2022. PMID: 34351426 Clinical Trial.
Donor-derived CARCIK-CD19 cells engineered with Sleeping Beauty transposon in acute lymphoblastic leukemia relapsed after allogeneic transplantation.
Lussana F, Magnani CF, Galimberti S, Gritti G, Gaipa G, Belotti D, Cabiati B, Napolitano S, Ferrari S, Moretti A, Buracchi C, Borleri GM, Rambaldi B, Rizzuto G, Grassi A, Paganessi M, Meli C, Tettamanti S, Risca G, Pais G, Spinozzi G, Benedicenti F, Cazzaniga G, Capelli C, Gotti E, Introna M, Golay J, Montini E, Balduzzi A, Valsecchi MG, Dastoli G, Rambaldi A, Biondi A. Lussana F, et al. Among authors: gotti e. Blood Cancer J. 2025 Apr 3;15(1):54. doi: 10.1038/s41408-025-01260-6. Blood Cancer J. 2025. PMID: 40180925 Free PMC article. Clinical Trial.
Optimized GMP-grade production of non-viral Sleeping Beauty-generated CARCIK cells for enhanced fitness and clinical scalability.
Pisani I, Melita G, de Souza PB, Galimberti S, Savino AM, Sarno J, Landoni B, Crippa S, Gotti E, Cuofano C, Pedrini O, Capelli C, Matera G, Belotti D, Cesana S, Cabiati B, Quaroni M, Colombo V, Mazza M, Vergani B, Gaimari A, Nicolini F, Tazzari M, Bocchini M, Serafini M, Rambaldi A, Rambaldi B, Dastoli G, Biondi A, Gaipa G, Introna M, Golay J, Tettamanti S. Pisani I, et al. Among authors: gotti e. J Transl Med. 2025 May 19;23(1):559. doi: 10.1186/s12967-025-06416-3. J Transl Med. 2025. PMID: 40390044 Free PMC article.
Post-transplant Kaposi's sarcoma.
Gotti E, Remuzzi G. Gotti E, et al. J Am Soc Nephrol. 1997 Jan;8(1):130-7. doi: 10.1681/ASN.V81130. J Am Soc Nephrol. 1997. PMID: 9013458 Review. No abstract available.
Antibody cases.
Poli F, Haworth S, Nocco A, Gotti E, Boschiero L, Dissegna E, Libetta C, Pellegrini C, Benazzi E, Scalamogna M. Poli F, et al. Among authors: gotti e. Clin Transpl. 2006:483-8. Clin Transpl. 2006. PMID: 18365408 No abstract available.
Paricalcitol for secondary hyperparathyroidism in renal transplantation.
Trillini M, Cortinovis M, Ruggenenti P, Reyes Loaeza J, Courville K, Ferrer-Siles C, Prandini S, Gaspari F, Cannata A, Villa A, Perna A, Gotti E, Caruso MR, Martinetti D, Remuzzi G, Perico N. Trillini M, et al. Among authors: gotti e. J Am Soc Nephrol. 2015 May;26(5):1205-14. doi: 10.1681/ASN.2013111185. Epub 2014 Sep 5. J Am Soc Nephrol. 2015. PMID: 25194004 Free PMC article. Clinical Trial.
121 results